• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part I.

作者信息

Lee Dong Ock, Hong Yeon Hee, Cho Moon Kyoung, Choi Young Sik, Chun Sungwook, Chung Youn-Jee, Hong Seung Hwa, Hwang Kyu Ri, Kim Jinju, Kim Hoon, Lee Dong-Yun, Lee Sa Ra, Park Hyun-Tae, Seo Seok Kyo, Shin Jung-Ho, Song Jae Yen, Yi Kyong Wook, Paik Haerin, Lee Ji Young

机构信息

Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.

Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

J Menopausal Med. 2024 Apr;30(1):1-23. doi: 10.6118/jmm.24000.

DOI:10.6118/jmm.24000
PMID:38714490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11103071/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d677/11103071/82da2a570d7c/jmm-30-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d677/11103071/82da2a570d7c/jmm-30-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d677/11103071/82da2a570d7c/jmm-30-1-g001.jpg

相似文献

1
The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part I.《2024年骨质疏松症指南——韩国更年期协会：第一部分》
J Menopausal Med. 2024 Apr;30(1):1-23. doi: 10.6118/jmm.24000.
2
The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part II.《2024年骨质疏松症指南 - 韩国更年期协会：第二部分》
J Menopausal Med. 2024 Aug;30(2):55-77. doi: 10.6118/jmm.300001.
3
Corrigendum: 2023 Korean Society of Menopause - Osteoporosis Guidelines Part I.勘误：2023年韩国更年期学会 - 骨质疏松症指南 第一部分。
J Menopausal Med. 2024 Aug;30(2):126. doi: 10.6118/jmm.300002.
4
The 2017 hormone therapy position statement of The North American Menopause Society.《北美绝经学会 2017 年激素治疗立场声明》。
Menopause. 2018 Nov;25(11):1362-1387. doi: 10.1097/GME.0000000000001241.
5
2013 Up-date of the consensus statement of the Spanish Menopause Society on postmenopausal osteoporosis.2013 年西班牙绝经学会绝经后骨质疏松症共识声明更新。
Maturitas. 2013 Sep;76(1):99-107. doi: 10.1016/j.maturitas.2013.05.021. Epub 2013 Jul 1.
6
The 2017 hormone therapy position statement of The North American Menopause Society.北美更年期协会2017年激素治疗立场声明。
Menopause. 2017 Jul;24(7):728-753. doi: 10.1097/GME.0000000000000921.
7
Vasomotor symptoms and osteoporosis in Korean postmenopausal women.韩国绝经后女性的血管舒缩症状与骨质疏松症
Maturitas. 2016 May;87:27-32. doi: 10.1016/j.maturitas.2016.02.007. Epub 2016 Feb 12.
8
The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause.化疗所致绝经女性骨健康评估中对实践指南的遵循情况
J Support Oncol. 2006 Jun;4(6):295-8, 304.
9
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.欧洲绝经学会（EMAS）和国际妇科肿瘤学会（IGCS）关于妇科癌症后管理绝经的立场声明：关注绝经症状和骨质疏松症。
Maturitas. 2020 Apr;134:56-61. doi: 10.1016/j.maturitas.2020.01.005. Epub 2020 Feb 11.
10
Association between osteoporosis and periodontal disease among menopausal women: The 2013-2015 Korea National Health and Nutrition Examination Survey.绝经后妇女骨质疏松症与牙周病的相关性：2013-2015 年韩国国家健康与营养检查调查。
PLoS One. 2022 Mar 17;17(3):e0265631. doi: 10.1371/journal.pone.0265631. eCollection 2022.

本文引用的文献

1
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society.绝经后女性骨质疏松症的管理：北美更年期协会2021年立场声明
Menopause. 2021 Sep 1;28(9):973-997. doi: 10.1097/GME.0000000000001831.
2
Osteoporosis Prevention, Screening, and Diagnosis: ACOG Clinical Practice Guideline No. 1.骨质疏松症的预防、筛查与诊断：美国妇产科医师学会临床实践指南第1号
Obstet Gynecol. 2021 Sep 1;138(3):494-506. doi: 10.1097/AOG.0000000000004514.
3
Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement.
成人维生素 D 缺乏症筛查：美国预防服务工作组推荐声明。
JAMA. 2021 Apr 13;325(14):1436-1442. doi: 10.1001/jama.2021.3069.
4
VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population.维生素 D 和欧米伽-3 试验（VITAL）：维生素 D 补充剂对美国人群跌倒风险的影响。
J Clin Endocrinol Metab. 2020 Sep 1;105(9):2929-38. doi: 10.1210/clinem/dgaa311.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.美国临床内分泌医师协会/美国内分泌学会 2020 年绝经后骨质疏松症诊断和治疗临床实践指南更新版
Endocr Pract. 2020 May;26(Suppl 1):1-46. doi: 10.4158/GL-2020-0524SUPPL.
6
Position Statement on the Use of Bone Turnover Markers for Osteoporosis Treatment.关于使用骨转换标志物进行骨质疏松症治疗的立场声明。
J Bone Metab. 2019 Nov;26(4):213-224. doi: 10.11005/jbm.2019.26.4.213. Epub 2019 Nov 30.
7
Incidence and Management Trends of Osteoporotic Vertebral Compression Fractures in South Korea: A Nationwide Population-Based Study.韩国骨质疏松性椎体压缩骨折的发病率及治疗趋势：一项基于全国人口的研究
Asian Spine J. 2020 Apr;14(2):220-228. doi: 10.31616/asj.2019.0051. Epub 2019 Nov 1.
8
Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region.亚太地区骨质疏松症治疗短期监测中骨转换标志物应用的共识声明。
J Clin Densitom. 2021 Jan-Mar;24(1):3-13. doi: 10.1016/j.jocd.2019.03.004. Epub 2019 Mar 20.
9
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.绝经后妇女骨质疏松症的药物治疗：内分泌学会临床实践指南*。
J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221.
10
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.维生素 D 补充剂与癌症和心血管疾病的预防。
N Engl J Med. 2019 Jan 3;380(1):33-44. doi: 10.1056/NEJMoa1809944. Epub 2018 Nov 10.